ALAFY logo

AFYREN SAS Stock Price

ENXTPA:ALAFY Community·€58.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ALAFY Share Price Performance

€2.23
-0.09 (-3.88%)
€2.23
-0.09 (-3.88%)
Price €2.23

ALAFY Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
1 Reward

AFYREN SAS Key Details

€2.7m

Revenue

€2.4m

Cost of Revenue

€308.0k

Gross Profit

€11.7m

Other Expenses

-€11.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.43
11.39%
-420.13%
5.3%
View Full Analysis

About ALAFY

Founded
2012
Employees
130
CEO
Nicolas Sordet
WebsiteView website
afyren.com

AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers biobased organic acids, including acetic, propionic, butyric, isobutyric, valeric, isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.

Recent ALAFY News & Updates

Recent updates

No updates